NEW YORK (GenomeWeb) – Innovate UK said today that it has designated up to £5 million ($6.6 million) to support capital investment in equipment that increases the UK’s capacity to develop and commercialize genomic analysis technologies.
The funding is part of the UK government's £210 million "data-to-early-diagnosis and precision medicine challenge" under its Industrial Strategy Challenge Fund, which aims to encourage the business and research communities to create new tools to diagnose diseases earlier and more easily.
Projects seeking funding for genomics advancement under this newly announced pledge should be led by a business with a relevant manufacturing facility — potentially in collaboration with academia or other companies — and should be focused on taking novel products to market, Innovate UK said.
Applicants are also encouraged to propose work that will build partnerships between public and private organizations. A briefing event discussing the funding opportunity is scheduled for June 22 and the project registration deadline is July 11.